Vaccine efficacy of recombinant GAPDH of Edwardsiella tarda against Edwardsiellosis

58Citations
Citations of this article
28Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Thirty-seven kilodalton glyceraldehyde-3-phosphate dehydrogenase (GAPDH) of Edwardsiella tarda was suggested to be an effective vaccine candidate against E. tarda infection in previous research. For developing a vaccine, obtaining GAPDH in large quantities is necessary. In this study, we determined the complete nucleotide sequence of the gene that encodes GAPDH of E. tarda, and overexpressed the GAPDH of E. tarda by using the Escherichia coli expression system. We immunized Japanese flounder with recombinant GAPDH (rGAPDH) and evaluated its vaccine efficacy. Our results showed that rGAPDH effectively protected Japanese flounder from experimental E. tarda infection, and will contribute to the development of a vaccine against E. tarda.

Cite

CITATION STYLE

APA

Liu, Y., Oshima, S. I., Kurohara, K., Ohnishi, K., & Kawai, K. (2005). Vaccine efficacy of recombinant GAPDH of Edwardsiella tarda against Edwardsiellosis. Microbiology and Immunology, 49(7), 605–612. https://doi.org/10.1111/j.1348-0421.2005.tb03652.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free